User: An 85-year-old woman was brought to the emergency department after losing consciousness. Her daughter reported a sudden onset of sweating, palpitations, and feeling cold before she lost consciousness approximately 45 minutes after finishing dinner. There was no reported chest pain, shortness of breath, or urinary incontinence. She had experienced similar but milder symptoms three times in the previous two weeks, each time recovering without assistance. She also reported headaches over the previous few days and an unintentional weight loss of 2 to 3 kg over the last few months.
Hello, Chief Resident here.
This case presents an 85-year-old female with recurrent episodes of autonomic instability (sweating, palpitations, feeling cold) culminating in a syncopal event shortly after a meal. The combination of postprandial timing, constitutional symptoms (weight loss), and new-onset headaches in an elderly patient necessitates a broad differential ranging from metabolic disturbances to occult malignancy or vasculitis.
Reactive Hypoglycemia (specifically Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome - NIPHS or Insulinoma): (45%)
The timing (45 minutes post-meal) is highly suggestive of postprandial hypoglycemia. While reactive hypoglycemia is often associated with gastric surgery (dumping syndrome), in an elderly patient with weight loss, we must consider an insulinoma or a paraneoplastic process producing insulin-like growth factors.
Pheochromocytoma: (25%)
The "classic triad" of palpitations, sweating, and headache, combined with weight loss, is highly suspicious. While syncope is less common than hypertension, orthostatic hypotension or arrhythmias associated with catecholamine surges can cause loss of consciousness.
Giant Cell Arteritis (GCA): (15%)
In an 85-year-old with new headaches and weight loss, GCA must be ruled out. While it doesn't typically cause syncope, systemic vasculitis can lead to various neurological presentations or be associated with other paraneoplastic phenomena.
Cardiac Arrhythmia (e.g., Sick Sinus Syndrome or Paroxysmal AV Block): (10%)
Syncope in the elderly is cardiac until proven otherwise. The palpitations could represent a tachy-brady syndrome, though the specific postprandial timing makes this less likely than a metabolic cause.
Postprandial Hypotension: (5%)
A common cause of syncope in the elderly where blood pressure drops significantly after eating due to splanchnic blood pooling. However, this usually doesn't present with significant weight loss or headaches.
Next Steps: I would immediately check her orthostatic vitals and bedside glucose. If she is currently asymptomatic, the postprandial nature of the event is the strongest lead.
Hello Attending Consultant here.
Critique of plan:
Refined 6-point recommendations:
Hello, Expert Clinician here.
Endogenous hyperinsulinemic hypoglycemia, most likely insulinoma, causing recurrent neuroglycopenic syncope with autonomic prodrome.
The strongest clue is the stereotyped autonomic warning symptoms before LOC: sweating, palpitations, feeling cold. That triad strongly suggests adrenergic response to hypoglycemia. Syncope/LOC then reflects neuroglycopenia. Recurrent episodes over 2 weeks, with spontaneous recovery, also fit intermittent hypoglycemia.
The key pivot is that although the episode occurred 45 minutes after dinner, which might tempt one toward postprandial hypotension or “reactive hypoglycemia,” in an 85-year-old with weight loss, recurrent adrenergic episodes plus LOC should make you think first of documented hypoglycemia until proved otherwise, especially endogenous hyperinsulinism.
Insulinoma / endogenous hyperinsulinemic hypoglycemia
- Fits: recurrent episodes, adrenergic prodrome, LOC, weight loss can occur from altered eating behavior or malignancy concern; symptoms may occur fasting or postprandially.
- Against: classic insulinoma is more often fasting-related than clearly postprandial, but postprandial episodes can occur.
Postprandial hypoglycemia not due to insulinoma
- Includes reactive hypoglycemia, medication-related, or less commonly non-insulinoma pancreatogenous hypoglycemia.
- Fits: episode after a meal.
- Against: in an elderly woman without known gastric surgery, this is less compelling; recurrent true syncope is more concerning for a pathologic cause.
Postprandial hypotension
- Fits: elderly patient, event after dinner, syncope after meals is common in older adults.
- Against: the adrenergic symptoms are more suggestive of hypoglycemia than hypotension; headaches and weight loss are not explained.
Cardiac arrhythmia
- Fits: elderly patient with syncope; palpitations may precede LOC.
- Against: the sweating/cold feeling stereotyped before each episode and recurrent meal association are less typical; still must be excluded because of age/risk.
Pheochromocytoma
- Fits: headache, palpitations, sweating, weight loss.
- Against: syncope is not a typical dominant manifestation; meal-triggered episodes are not classic; far less likely than hypoglycemia.
Giant cell arteritis
- Fits: new headache, weight loss, age.
- Against: does not explain recurrent autonomic episodes with syncope. Important comorbidity to consider, not the unifying diagnosis.
The earlier discussion appropriately noticed hypoglycemia and pheochromocytoma, but the central issue is not just “postprandial syncope.” It is autonomic warning symptoms followed by LOC, which is much more diagnostically specific for hypoglycemia than for vasovagal or hemodynamic postprandial syncope. Also, pheochromocytoma was overemphasized.
Document Whipple’s triad during an episode:
1. Symptoms consistent with hypoglycemia
2. Low plasma glucose at that time
3. Resolution with glucose
During the episode, obtain:
- Plasma glucose
- Insulin
- C-peptide
- Proinsulin
- Beta-hydroxybutyrate
- Sulfonylurea/meglitinide screen
If she is currently symptomatic in the ED, this should be done immediately before dextrose, if safely possible.
If glucose is low or she is altered: treat hypoglycemia immediately with IV dextrose, then monitor closely. Given recurrent syncope at age 85, she also still needs:
- ECG
- Telemetry
- Basic syncope evaluation
In recurrent “spells” with sweating, palpitations, and confusion/syncope, always think hypoglycemia first and try to capture labs during symptoms; imaging comes only after biochemical confirmation.
User: Upon arrival of the emergency medical services, the patient was still unconscious. Her temperature was 36.4°C, blood pressure 135/65 mm Hg, heart rate 78 beats per minute, and respiratory rate 12 breaths per minute. Oxygen saturation was 99% on room air. Her eyes were open, pupils were equal and reactive to light, and cardiovascular and pulmonary examinations were normal. Painful stimuli elicited a withdrawal response, but she had incomprehensible speech and could not follow commands. An electrocardiogram was normal. Her random blood sugar was 40 mg/dL. She was immediately given 100 ml of 10% intravenous glucose and promptly regained consciousness.
Hello, Chief Resident here.
The clinical picture has sharpened significantly with the documentation of Whipple’s Triad: symptoms of neuroglycopenia (unconsciousness/incomprehensible speech), a documented low blood sugar (40 mg/dL), and prompt resolution of symptoms upon administration of glucose.
Insulinoma (including Malignant Insulinoma): (60%)
While classically associated with fasting, a significant minority of insulinomas (up to 10%) can present with postprandial symptoms. Given her age and weight loss, a malignant insulinoma must be considered, as it would explain both the hypoglycemia and the constitutional decline.
Reasoning: The severity of the hypoglycemia (40 mg/dL) and the recurrent nature are hallmarks of endogenous hyperinsulinism.
Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS) / Nesidioblastosis: (15%)
This condition specifically causes postprandial hyperinsulinemic hypoglycemia due to beta-cell hypertrophy.
Reasoning: Fits the postprandial timing perfectly, though it is rarer than insulinoma in this age group.
Non-Islet Cell Tumor Hypoglycemia (NICTH): (15%)
Certain tumors (e.g., mesenchymal tumors, hepatocellular carcinoma) secrete "Big-IGF-2," which mimics insulin action.
Reasoning: This would explain the profound hypoglycemia and the unintentional weight loss.
Factitious Hypoglycemia or Medication-Induced: (5%)
Accidental or intentional ingestion of sulfonylureas or insulin.
Reasoning: Always a possibility in the elderly (e.g., taking a spouse's medication), though less likely to explain the weight loss and headaches.
Adrenal Insufficiency: (5%)
Glucocorticoid deficiency can lead to hypoglycemia and weight loss.
Reasoning: Usually presents with hypotension and electrolyte abnormalities (hyponatremia/hyperkalemia), which are absent here.
Management Note: The patient should be started on frequent, small, low-glycemic-index meals to prevent further drops while the biochemical workup is completed. Given the headaches and weight loss, I would also keep a low threshold for imaging the head and chest/abdomen to look for primary malignancy or metastases.
Hello Attending Consultant here.
Critique of plan:
Refined 6-point recommendations:
Hello, Expert Clinician here.
She now has proven hypoglycemic syncope/neuroglycopenia by Whipple’s triad:
- compatible symptoms/signs: unconsciousness, inability to follow commands
- documented low glucose: 40 mg/dL
- prompt reversal with IV glucose
The leading unifying diagnosis is endogenous hyperinsulinemic hypoglycemia, with insulinoma still high on the list, but at this point the more precise statement is:
Recurrent severe hypoglycemia causing neuroglycopenic syncope, most likely due to endogenous hyperinsulinism until proven otherwise.
The case is no longer primarily “syncope.”
The decisive pivot is that she was still obtunded when EMS arrived and immediately woke up after dextrose. That converts this from a broad syncope differential into a hypoglycemia differential.
Why it fits
- recurrent episodes over weeks
- adrenergic prodrome: sweating, palpitations
- neuroglycopenia: LOC, confusion
- relief with glucose
- weight loss may reflect reduced intake from recurrent spells
Why it may not fit perfectly
- symptoms seem postprandial, whereas classic insulinoma is often fasting-related
But insulinoma can still present with mixed or postprandial episodes.
Why it fits
- timing about 45 minutes after dinner
- recurrent meal-related episodes
- could produce the same adrenergic and neuroglycopenic manifestations
Why less certain
- much less common, especially without a history suggesting prior gastric surgery or other predisposition
- still requires biochemical proof of inappropriate insulin secretion
Why it fits
- elderly patients can have accidental ingestion, dispensing errors, or access to others’ medications
- causes endogenous insulin secretion pattern
- can be recurrent and severe
Why less likely
- no medication history given yet
- does not explain headaches/weight loss, though those may be unrelated
Why it fits
- age and weight loss
- can cause recurrent severe hypoglycemia
Why less likely
- adrenergic postprandial pattern is less classic
- would usually show suppressed insulin/C-peptide, so this remains a biochemical branch-point diagnosis
Why it fits
- can cause hypoglycemia, weight loss
Why less likely
- vitals are stable, no shock pattern, no obvious systemic illness from the stem
- autonomic spells recurring after meals are less typical
Why they no longer lead
- normal ECG does not fully exclude arrhythmia, but the event was clearly glucose-responsive
- these do not explain blood glucose of 40 mg/dL with prompt neurologic recovery after dextrose
Obtain a critical sample during hypoglycemia—this is the essential next step.
During a spontaneous recurrent episode, before giving glucose if safely possible, send:
- plasma glucose
- insulin
- C-peptide
- proinsulin
- beta-hydroxybutyrate
- sulfonylurea/meglitinide screen
If a pre-treatment sample from EMS/ED is available, retrieve it urgently.
Because she has had recurrent severe hypoglycemia with loss of consciousness, she should be:
- admitted
- placed on frequent glucose monitoring
- maintained on continuous dextrose support if needed
- given regular carbohydrate intake once safe to eat
Do not rely only on “eat small frequent meals” in an 85-year-old with severe recurrent episodes.
These remain important, but they are not the immediate pivot. They may be:
- related to recurrent hypoglycemia
- a clue to occult malignancy
- a separate process altogether
They should broaden the workup, but not distract from first establishing the mechanism of hypoglycemia.
Once Whipple’s triad is demonstrated, the evaluation should pivot from “Why did she faint?” to “Why is she hypoglycemic?”
In recurrent unexplained episodes with sweating and palpitations, always try to capture a critical sample during hypoglycemia before treatment if safely feasible.
User: In the emergency department, the patient appeared well and was alert and oriented. Her vital signs remained stable. Her body-mass index was 22. Physical examination showed no skin abnormalities, no nuchal rigidity, and no motor or sensory deficits. Her medical history was significant only for hypertension, for which she was taking triamterene–hydrochlorothiazide. She had no history of diabetes mellitus, never smoked, and did not consume alcohol. She was of Eritrean descent and had emigrated two weeks previously. Family history was negative for cardiovascular, neurologic, or autoimmune diseases.
Resident:
Hello, Chief Resident here.
The clinical picture has shifted dramatically with the addition of one critical piece of information: the patient is of Eritrean descent and emigrated only two weeks ago. This, combined with the documented postprandial hyperinsulinemic hypoglycemia, points toward a specific, geographically-linked autoimmune phenomenon.
Insulin Autoimmune Syndrome (Hirata Disease): (70%)
This is the leading diagnosis. It is characterized by high titers of insulin autoantibodies that bind insulin after a meal (leading to early hyperglycemia) and then dissociate unpredictably, causing massive, inappropriate late postprandial hypoglycemia.
Reasoning: While most common in Japanese populations, it is the second most common cause of endogenous hyperinsulinemic hypoglycemia in some other groups. Certain medications (especially those with sulfhydryl groups like methimazole, but occasionally others) can trigger it. The "feeling cold" and sweating are classic adrenergic responses to the sudden insulin surge as antibodies release their load.
Insulinoma: (15%)
Still a possibility in any elderly patient with endogenous hyperinsulinism, but the strictly postprandial nature and the new demographic information make Hirata disease more likely.
Reasoning: Weight loss could be seen in malignant insulinoma, but the timing is more classic for IAS.
Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS): (10%)
Postprandial hyperinsulinism due to beta-cell hypertrophy.
Reasoning: Fits the timing, but less likely to explain the sudden onset over two weeks and the constitutional symptoms.
Factitious Hypoglycemia: (5%)
Reasoning: Less likely given the recent migration and lack of access to insulin/secretagogues, but must always be ruled out by C-peptide and drug screens.
The headaches and weight loss might be secondary to the metabolic stress of recurrent severe hypoglycemia or could suggest an underlying systemic autoimmune process. If Hirata Disease is confirmed, management involves small, frequent, low-carbohydrate meals and occasionally corticosteroids or immunosuppressants.
Chief Resident's Conclusion: The recent migration and postprandial timing are the "smoking guns" for Insulin Autoimmune Syndrome. I suspect her insulin levels will be paradoxically and massively elevated.
Hello Attending Consultant here.
Critique of plan:
Refined 6-point recommendations:
Hello, Expert Clinician here.
Insulin autoimmune syndrome (IAS, Hirata disease) causing recurrent postprandial hyperinsulinemic hypoglycemia.
The new details shift the case away from insulinoma as the default:
IAS is particularly attractive because it often presents with:
- postprandial hypoglycemia
- very high insulin levels
- spontaneous recurrent episodes
- absence of pancreatic tumor
Fits
- postprandial pattern
- recurrent severe hypoglycemia
- no diabetes
- spontaneous recovery between episodes
- possible drug trigger
- can occur in older adults and may be missed if clinicians focus only on insulinoma
Against
- relatively uncommon
- weight loss/headaches are not classic defining features
Fits
- endogenous hyperinsulinemic hypoglycemia can certainly cause this presentation
- recurrent severe episodes with neuroglycopenia
Against
- insulinoma more often causes fasting hypoglycemia, though not exclusively
- the repeated post-meal timing makes IAS more compelling right now
Fits
- can mimic endogenous hyperinsulinism
- severe recurrent episodes possible in older adults
Against
- no diabetes history, no such medication reported
- still must be ruled out biochemically
Fits
- postprandial hyperinsulinemia
Against
- rarer and usually a diagnosis after more common explanations are excluded
Fits
- weight loss
Against
- would usually show suppressed insulin/C-peptide, so less likely given the clinical pattern suggesting hyperinsulinism
The most important pivot is not simply that she is hypoglycemic, but that her episodes are reproducibly postprandial in a nondiabetic patient, which is a classic clue for IAS rather than classic insulinoma.
Obtain or retrieve a critical hypoglycemia sample, specifically:
- plasma glucose
- insulin
- C-peptide
- proinsulin
- beta-hydroxybutyrate
- sulfonylurea/meglitinide screen
And now, crucially:
- insulin autoantibodies
If available, try to recover any pre-dextrose blood from the ED/EMS encounter.
If IAS is confirmed and symptoms are significant, treatment may include:
- dietary modification
- short-course glucocorticoids
- rarely other immunomodulatory therapies
In a nondiabetic patient with recurrent postprandial hypoglycemia, especially if insulin levels later prove strikingly high, think insulin autoimmune syndrome before chasing a pancreatic tumor.
User: Initial laboratory investigations showed a complete blood count within the normal range, with a normal Total Leukocyte Count (TLC). The plasma glucose level was 176.4 mg/dL and the glycated hemoglobin (HbA1c) was 5.5%. Kidney Function Tests (KFT) showed a sodium level of 130 mmol/L, potassium 3.7 mmol/L, and creatinine 0.51 mg/dL. Liver Function Tests (LFT) including AST, ALT, alkaline phosphatase, γ-glutamyltransferase, and total bilirubin were all normal. Calcium was 9.1 mg/dL, C-reactive protein was 3 mg/L (normal <8), and TSH was normal. The patient was admitted for further evaluation.
Resident:
Hello, Chief Resident here.
The initial laboratory results provide several important negative findings that help narrow our focus, while also introducing a mild electrolyte abnormality.
Insulin Autoimmune Syndrome (IAS / Hirata Disease): (75%)
The postprandial timing remains the strongest clinical lead. The normal CRP and TLC make a primary inflammatory or infectious cause for her constitutional symptoms less likely, supporting the idea that the "spells" themselves or a specific autoimmune process are the primary drivers.
Reasoning: The demographic and clinical pattern (postprandial hypoglycemia in a non-diabetic) is classic for IAS.
Insulinoma: (15%)
Remains a possibility. While insulinomas often cause fasting hypoglycemia, they can present postprandially. The weight loss still keeps this on the radar.
Reasoning: Endogenous hyperinsulinism is confirmed by the glucose response; the source (antibody vs. tumor) is the next question.
Adrenal Insufficiency (Primary or Secondary): (5%)
The hyponatremia (130 mmol/L) and weight loss could be explained by glucocorticoid deficiency.
Reasoning: Hypoglycemia is a known manifestation, though the postprandial autonomic surges are less typical than for IAS.
Non-Islet Cell Tumor Hypoglycemia (NICTH): (5%)
Reasoning: Still possible given the weight loss, though the postprandial timing is less common than in IAS.
Management Note: I would discontinue the triamterene-hydrochlorothiazide immediately, both to address the hyponatremia and because thiazides/sulfonamide-derivatives are potential triggers for IAS. I would also monitor her blood pressure closely and start a low-simple-carbohydrate diet with frequent small meals.
Chief Resident's Conclusion: The normal CRP pushes us further away from vasculitis and toward a primary metabolic/autoimmune insulin disorder. The hyponatremia is likely diuretic-induced but warrants a quick check of adrenal function. The focus remains on confirming Insulin Autoimmune Syndrome.
Hello Attending Consultant here.
Critique of plan:
Refined 6-point recommendations:
Hello, Expert Clinician here.
Still most likely: recurrent hypoglycemia due to endogenous hyperinsulinemia, with insulin autoimmune syndrome (IAS) currently favored.
They mostly help by excluding common systemic causes of hypoglycemia:
These results do not distinguish IAS from insulinoma; that requires critical-sample biochemistry during hypoglycemia.
Why it fits
- repeated postprandial hypoglycemia
- nondiabetic patient
- otherwise well between episodes
- possible medication trigger
- no evidence yet of organ failure or critical illness
Why not proven yet
- needs insulin autoantibodies
- must still exclude sulfonylurea exposure and insulinoma biochemically
Why it fits
- Whipple’s triad
- recurrent severe neuroglycopenic episodes
Why slightly less favored
- pattern seems more postprandial than fasting
Why it fits
- can present exactly like endogenous hyperinsulinism
- elderly patients are vulnerable to medication mix-ups
Why less favored
- no known diabetes meds, but still must be tested
Why it fits
- weight loss, hyponatremia, hypoglycemia can occur
Why less favored
- normal potassium, stable hemodynamics, and strongly meal-related episodes argue against it as the main explanation
The pivot remains: this is not unexplained syncope; it is documented hypoglycemic neuroglycopenia.
The newer pivot is that routine labs are largely normal, making a specific hyperinsulinemic disorder more likely.
Get the mechanism of hypoglycemia now.
Highest-yield tests:
During spontaneous hypoglycemia, obtain:
- plasma glucose
- insulin
- C-peptide
- proinsulin
- beta-hydroxybutyrate
- sulfonylurea/meglitinide screen
Also send:
- insulin autoantibodies
If no pre-dextrose sample exists from the original event, the patient should be monitored closely to capture one safely if hypoglycemia recurs.
Because of weight loss + headache + recent emigration, I would also consider:
- morning cortisol
- serum/urine osmolality and urine sodium for hyponatremia
- targeted infectious screening if clinically indicated (e.g., TB/malaria based on exposure/symptoms)
But these are secondary to establishing the biochemical cause of the hypoglycemia.
Normal routine labs do not reassure you in severe recurrent hypoglycemia; they should instead push you toward a focused “critical sample” strategy to identify endogenous hyperinsulinism, drug effect, or autoimmune insulin binding.
User: Five hours after admission, the patient's blood sugar decreased to 35 mg/dL despite adequate food intake. She was sweating profusely and felt very weak but remained conscious. The glucose level was restored with 120 ml of 40% glucose infusion. Within an hour, her blood sugar was 193 mg/dL. A continuous infusion of 5% glucose was started, but hypoglycemia recurred. The concentration was increased to 20% glucose at 2000 ml per 24 hours. A low-dose corticotropin stimulation test showed a cortisol increase from 10.8 to 23.7 µg/dL after 30 minutes, ruling out hypocortisolism.
Resident:
Hello, Chief Resident here.
The case has reached a critical juncture. We now have a recurrent, severe hypoglycemic event (35 mg/dL) occurring despite oral intake and requiring high-concentration IV dextrose (20% glucose) to maintain euglycemia. This confirms a state of profound, persistent endogenous hyperinsulinism.
Insulin Autoimmune Syndrome (IAS / Hirata Disease): (80%)
The severity and the "brittle" nature of the glucose levels (crashing despite intake, then requiring massive dextrose) are very characteristic of IAS. In IAS, the antibodies act as a reservoir, releasing massive amounts of insulin unpredictably.
Reasoning: The postprandial trigger and the demographic context remain the strongest drivers.
Insulinoma: (15%)
A high-secreting insulinoma can certainly require 20% dextrose.
Reasoning: While the timing was initially postprandial, she is now having "fasting" or "inter-meal" hypoglycemia while admitted, which is the classic presentation of insulinoma.
Non-Islet Cell Tumor Hypoglycemia (NICTH): (3%)
Reasoning: Less likely given the autonomic symptoms (NICTH often has fewer adrenergic symptoms than hyperinsulinemic states) and the normal cortisol.
Factitious Hypoglycemia: (2%)
Reasoning: Extremely unlikely in a supervised hospital setting with a 20% dextrose requirement, but a sulfonylurea screen is still mandatory.
The patient is currently on a high-dose glucose "rollercoaster."
* Immediate Action: If IAS is suspected, Acarbose can sometimes help by slowing carbohydrate absorption and reducing the initial insulin surge that "loads" the antibodies.
* Steroids: If IAS is confirmed, starting Prednisone (e.g., 40–60 mg) often results in rapid stabilization of glucose levels by decreasing antibody production and affinity.
* Octreotide: Could be considered if an insulinoma is suspected, though it can occasionally worsen hypoglycemia in IAS or certain insulinomas.
Chief Resident's Conclusion: We have confirmed a state of severe endogenous hyperinsulinism. Given the demographic and the postprandial onset, Insulin Autoimmune Syndrome is the most likely culprit. We are awaiting the "critical sample" and antibody titers to confirm.
Hello Attending Consultant here.
Critique of plan:
Refined 6-point recommendations:
Hello, Expert Clinician here.
The best current diagnosis is still endogenous hyperinsulinemic hypoglycemia, and at this stage insulin autoimmune syndrome (IAS) remains the leading specific cause.
New features strongly support a persistent insulin-mediated process:
This is not simple starvation, adrenal failure, liver disease, renal failure, or sepsis. The physiology now points strongly toward inappropriate insulin effect.
Why it fits well
- often causes postprandial hypoglycemia
- can produce marked glycemic volatility with recurrent drops despite feeding
- can require large glucose loads because insulin bound to antibodies is released unpredictably
- no diabetes history
- possible medication trigger
- normal cortisol response removes a major endocrine mimic
Why not yet proven
- must show insulin autoantibodies
- needs critical-sample pattern consistent with insulin-mediated hypoglycemia
Why it still fits
- now she is also having hypoglycemia outside the immediate meal window
- severe recurrent episodes despite feeding are compatible with insulinoma
- endogenous hyperinsulinism remains a major possibility
Why slightly less favored
- the presentation started with a strongly postprandial pattern, which is a bit less classic for insulinoma
Why it fits
- can cause persistent recurrent hypoglycemia despite feeding
- can look exactly like endogenous hyperinsulinism
Why less likely
- no history suggesting access/use, but it still must be excluded with testing, not assumption
Why it fits
- weight loss raises the possibility
Why it is less likely now
- usually does not behave like this with clear adrenergic hyperinsulinemic-type spells
- would not be the first explanation for this pattern unless insulin/C-peptide are suppressed
The key pivot now is:
Hypoglycemia is recurring despite oral intake and continuous dextrose, while adrenal insufficiency has been excluded.
That means this is almost certainly a pathologic glucose-lowering process, most likely insulin-mediated.
If not already done, the single most important next step is to obtain and urgently process a critical sample from the 35 mg/dL episode:
At this point, because she has had recurrent observed hypoglycemia in the hospital, there is a major missed opportunity if a critical sample was not drawn during the latest event.
She needs safe stabilization while preventing recurrent neuroglycopenia:
When hypoglycemia persists despite feeding and adrenal insufficiency is excluded, think “inappropriate insulin action” and capture a critical sample immediately—before reflexively escalating imaging or empiric therapy.
User: The patient had another hypoglycemic episode with a blood sugar of 16.2 mg/dL accompanied by loss of consciousness. Concomitant laboratory testing showed an extremely high insulin level of 182 µU/mL and a C-peptide level of 2.0 ng/mL. A screening test for sulfonylureas was negative. Computed tomography (CT) of the abdomen showed no pancreatic mass or other intraabdominal abnormalities, but incidentally identified a suspicious lesion in the left breast. Subsequent magnetic resonance imaging (MRI) of the abdomen and endoscopic ultrasonography of the pancreas also showed no abnormalities.
Resident:
Hello, Chief Resident here.
We have now reached the biochemical confirmation of endogenous hyperinsulinemic hypoglycemia. The patient experienced a life-threatening glucose level of 16.2 mg/dL with loss of consciousness, and the "critical sample" results are the key to the final diagnosis.
Insulin Autoimmune Syndrome (IAS / Hirata Disease): (90%)
The biochemical pattern is the "smoking gun." In IAS, the insulin level is often disproportionately higher than the C-peptide level. An insulin-to-C-peptide ratio (in molar terms) >1 is highly suggestive of IAS.
Reasoning: The combination of extremely high insulin, mildly elevated C-peptide, postprandial onset, and negative pancreatic imaging in an elderly patient (especially with recent migration and thiazide use) is classic for IAS. The antibodies bind insulin, prolonging its half-life and interfering with the assay, leading to these "sky-high" values.
Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS): (5%)
Reasoning: This causes postprandial hyperinsulinism with negative imaging, but the insulin levels are rarely this extreme.
Malignant Insulinoma (Occult): (3%)
Reasoning: While EUS is excellent, a very small or ectopic insulinoma could be missed, but the biochemical ratio favors IAS.
Paraneoplastic Hypoglycemia (related to the breast lesion): (2%)
Reasoning: If the breast lesion is malignant, it could theoretically cause NICTH, but that would typically present with low insulin and low C-peptide. However, rare cases of ectopic insulin secretion by non-pancreatic tumors exist.
The patient is at high risk for further life-threatening drops.
* Immediate: Start Prednisone (e.g., 40–60 mg daily). Corticosteroids are the treatment of choice for IAS as they decrease antibody production and decrease the affinity of the antibodies for insulin, stabilizing the "reservoir" effect.
* Diet: Strict low-carbohydrate, frequent small meals to minimize the postprandial insulin surge that "charges" the antibody reservoir.
* Breast Workup: Urgent mammography and biopsy.
Chief Resident's Conclusion: The biochemical data (massive insulin, non-suppressed C-peptide) and negative pancreatic imaging strongly point to Insulin Autoimmune Syndrome. The suspicious breast lesion must be investigated as a potential malignancy that could be related (paraneoplastic) or a significant co-morbidity.
Hello Attending Consultant here.
Critique of plan:
Refined 6-point recommendations:
Hello, Expert Clinician here.
Insulin autoimmune syndrome (IAS, Hirata disease) causing endogenous hyperinsulinemic hypoglycemia.
At glucose 16.2 mg/dL, she had:
- Insulin 182 µU/mL: profoundly inappropriately elevated
- C-peptide 2.0 ng/mL: inappropriately non-suppressed
- Negative sulfonylurea screen
- No pancreatic lesion on CT, MRI, or EUS
That combination strongly argues for endogenous insulin effect without a localizable insulinoma, and the earlier postprandial pattern points especially toward IAS.
A practical discriminator here is the disproportionately high insulin relative to C-peptide, which is classic in IAS because insulin autoantibodies prolong insulin half-life and distort measured total insulin upward.
Fits: endogenous hyperinsulinemic hypoglycemia
Does not fit as well: triple-negative localization workup so far:
- pancreatic CT negative
- MRI negative
- EUS negative
A tiny occult insulinoma is still possible, but it is now less likely than IAS.
Fits: can produce high insulin and C-peptide
Against: screen negative
Fits: postprandial hypoglycemia, negative imaging
Against: less common, and the markedly elevated insulin level with this overall phenotype still favors IAS
Against strongly: would usually show suppressed insulin and C-peptide, which she does not
This is extraordinarily rare. The breast lesion is important, but it is not the best explanation for the current biochemical pattern.
The key pivot is:
Severe hypoglycemia with markedly elevated insulin, non-suppressed C-peptide, negative sulfonylurea screen, and negative pancreatic imaging.
That is the classic moment to think:
- insulin autoimmune syndrome
- then only secondarily occult insulinoma/nesidioblastosis
Order insulin autoantibodies now if not already sent.
This is the most important confirmatory test.
Helpful adjuncts:
- repeat critical-sample interpretation if needed
- beta-hydroxybutyrate if not already measured
- consider free vs total insulin if available
If insulin autoantibodies are positive, that would strongly confirm IAS.
Given recurrent life-threatening hypoglycemia:
- continue careful dextrose support
- frequent low-carbohydrate / low-glycemic meals
- stop potential triggering medications, especially triamterene–hydrochlorothiazide
- if hypoglycemia remains difficult to control, glucocorticoid therapy is reasonable, especially once IAS is strongly supported/confirmed
It needs standard oncologic evaluation:
- diagnostic mammography
- targeted ultrasound
- core biopsy
But it is probably a parallel finding, not the primary explanation for the hyperinsulinemic hypoglycemia.
When hypoglycemia occurs with very high insulin, detectable C-peptide, negative sulfonylurea screen, and no pancreatic lesion, think insulin autoimmune syndrome—especially if the episodes are postprandial.
User: Treatment with subcutaneous octreotide injections was started, and the patient's glucose levels stabilized. Testing for insulin antibodies returned strongly positive at a titer of more than 50 U/L (reference range 0 to 0.4). This confirmed a diagnosis of Insulin Autoimmune Syndrome (Hirata disease). Further evaluation of the breast lesion via biopsy revealed invasive ductal carcinoma.
Resident:
Hello, Chief Resident here.
The case has reached a definitive conclusion with the biochemical confirmation of Insulin Autoimmune Syndrome (IAS/Hirata Disease) and the simultaneous discovery of Invasive Ductal Carcinoma of the breast.
While IAS is often triggered by medications (like the thiazide this patient was taking), there is a known association between IAS and other autoimmune or neoplastic processes. In this case, the breast cancer may have acted as a systemic trigger for the immune dysregulation leading to IAS, or they may be two independent conditions occurring in an 85-year-old patient.
Hypoglycemia Management:
Oncological Management:
Follow-up:
Final Teaching Pearl:
In an elderly patient with "spells" and weight loss, always look for both the metabolic explanation (hypoglycemia) and the systemic one (malignancy). Insulin Autoimmune Syndrome should be suspected whenever there is severe hyperinsulinemia that does not match the C-peptide level or imaging, especially if symptoms are postprandial. The recent migration and medication use were the crucial clues in this complex presentation.
Hello Attending Consultant here.
Critique of resident plan:
Refined 6-point recommendations:
Hello, Expert Clinician here.
Confirmed Insulin Autoimmune Syndrome (IAS, Hirata disease) causing recurrent severe endogenous hyperinsulinemic hypoglycemia, with concurrent invasive ductal breast carcinoma.
IAS is now definitively established by:
- documented Whipple’s triad
- profound hypoglycemia with inappropriately high insulin
- non-suppressed C-peptide
- negative sulfonylurea screen
- no pancreatic lesion on CT, MRI, or EUS
- strongly positive insulin antibodies (>50 U/L; ref 0–0.4)
That is the decisive biochemical and clinical pattern.
Insulinoma
- Initially plausible due to endogenous hyperinsulinemic hypoglycemia.
- Now much less likely because pancreatic CT, MRI, and EUS were negative and insulin antibodies are strongly positive, which directly explains the syndrome.
Sulfonylurea-induced hypoglycemia
- Mimics endogenous hyperinsulinism.
- Excluded by the negative sulfonylurea screen.
Non-islet cell tumor hypoglycemia
- Considered because of weight loss and malignancy.
- Does not fit because this usually causes low insulin and low C-peptide, whereas this patient had marked hyperinsulinemia.
Adrenal insufficiency
- Mild hyponatremia and weight loss made it worth checking.
- Appropriately excluded by a normal corticotropin stimulation test.
The pivotal moment was the critical sample during profound hypoglycemia showing:
- glucose 16.2 mg/dL
- insulin 182 µU/mL
- C-peptide 2.0 ng/mL
- negative sulfonylurea screen
That established endogenous insulin-mediated hypoglycemia.
The second pivot was the strongly positive insulin antibody titer, which converted suspicion into confirmation of IAS.
The breast lesion explains the constitutional symptoms, especially weight loss, and possibly the headaches if those were nonspecific. It is most likely a coexisting diagnosis, though malignancy can sometimes coexist with immune dysregulation. It is not the primary mechanism of hypoglycemia here, because the hypoglycemia pattern is clearly insulin-antibody mediated rather than IGF-2 mediated.
Now that IAS is confirmed:
- Remove potential triggers permanently, especially triamterene–hydrochlorothiazide
- Continue frequent low-glycemic meals
- Continue short-term glucose support as needed
- Because octreotide stabilized her glucose, it is reasonable as a bridge, but the more standard disease-modifying treatment for significant IAS is:
- glucocorticoids if hypoglycemia remains severe or recurrent
- Follow serial:
- bedside glucoses
- insulin antibody titers if available
- need for dextrose support
For the breast cancer:
- proceed with formal staging and receptor profiling and involve oncology/surgery in an age- and goals-of-care–appropriate plan.
When severe hypoglycemia shows high insulin, non-suppressed C-peptide, negative sulfonylurea testing, and negative pancreatic imaging, check insulin autoantibodies—postprandial timing is a major clue to Insulin Autoimmune Syndrome.
User: The patient was started on a diet of frequent, small, low-carbohydrate meals and treatment with prednisone at a dose of 60 mg daily. A mastectomy with sentinel-lymph-node biopsy confirmed invasive ductal carcinoma with no neuroendocrine features. Over the following weeks, the glucose infusion and octreotide were discontinued, and the prednisone dose was slowly tapered. At a follow-up visit more than one year after discharge, the patient had no further episodes of severe hypoglycemia, although the insulin antibody titer remained strongly positive.
Resident:
Hello, Chief Resident here.
This case concludes with the successful management of a complex dual diagnosis in an 85-year-old patient. The clinical course confirms the classic behavior of Insulin Autoimmune Syndrome (IAS) and highlights the importance of a systematic approach to hypoglycemia.
The patient's recovery and one-year stability demonstrate the effectiveness of removing the trigger and using targeted immunosuppression. This case serves as a reminder that in the elderly, multiple significant pathologies (autoimmune and neoplastic) can present simultaneously.
Hello Attending Consultant here.
Critique of resident synthesis:
Refined 6-point recommendations:
Hello, Expert Clinician here.
Insulin Autoimmune Syndrome (IAS, Hirata disease) causing recurrent severe endogenous hyperinsulinemic hypoglycemia, with concurrent invasive ductal breast carcinoma as a separate coexisting illness.
This is now fully established by:
- Whipple’s triad
- recurrent profound hypoglycemia
- markedly elevated insulin during hypoglycemia
- inappropriately non-suppressed C-peptide
- negative sulfonylurea screen
- negative pancreatic CT/MRI/EUS
- strongly positive insulin autoantibodies
- clinical response to dietary carbohydrate restriction, glucocorticoids, and temporary octreotide
The breast cancer was evaluated appropriately and had no neuroendocrine features, which argues against it being the source of ectopic insulin secretion.
Insulinoma
- Initially very plausible.
- Became unlikely after negative high-quality pancreatic imaging and then was functionally displaced by the positive insulin antibody test.
Sulfonylurea-induced hypoglycemia
- Excluded by testing.
Non-islet cell tumor hypoglycemia
- Does not fit the biochemical profile because insulin would typically be suppressed.
Adrenal insufficiency
- Excluded with an adequate corticotropin stimulation response.
The key pivot was the critical sample during severe hypoglycemia, followed by the positive insulin antibody titer. That combination transformed a broad hypoglycemia differential into a specific diagnosis of IAS.
Two clinically important lessons emerge:
IAS can remit clinically even when insulin antibody titers remain strongly positive.
Persistent antibodies do not necessarily mean persistent symptomatic disease.
The breast carcinoma was likely a parallel diagnosis rather than the mechanism of hypoglycemia.
It explained the weight loss better than the hypoglycemia syndrome did, and pathology showed no neuroendocrine differentiation.
The most important successful management steps were:
- frequent, small, low-carbohydrate meals
- prednisone for severe/refractory IAS
- tapering off dextrose and octreotide once glucose stabilized
- removal of potential medication triggers
- definitive management of the breast cancer
Even though she is clinically well more than a year later, the priorities are:
- continued avoidance of possible trigger drugs
- education about recurrence symptoms
- periodic glucose monitoring if symptoms recur
- routine oncologic follow-up for breast cancer
- monitoring for steroid sequelae if any residual exposure-related issues remain
In IAS, treat the patient, not the antibody titer: hypoglycemia may resolve completely even while insulin autoantibodies remain strongly positive for months or years.